Bg pattern

ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el usuario

Acetilcisteína Tarbis 200 mg granulado para solución oral EFG

Lea todo el prospecto detenidamente antes de empezar a tomarusar este medicamento,porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
    1. Si tiene alguna duda, consulte a su médico, farmacéutico o enfermero.
  • Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.
    • Si experimenta efectos adversos, consulte a su médico, farmacéutico o enfermero, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.

Contenido del prospecto

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

  1. Qué es Acetilcisteína Tarbis y para qué se utiliza.
  2. Qué necesita saber antes de empezar a tomar Acetilcisteína Tarbis.
  3. Cómo tomar Acetilcisteína Tarbis.
  4. Posibles efectos adversos.
  5. Conservación de Acetilcisteína Tarbis.
  6. Contenido del envase e información adicional.

1. Qué es Acetilcisteína Tarbis y para qué se utiliza

Acetilcisteína, principio activo de este medicamento, pertenece a un grupo de medicamentos denominados mucolíticos y se utiliza para fluidificar las secreciones bronquiales excesivas y/o espesas.

Este medicamento está indicado para facilitar la eliminación del exceso de mocos y flemas en los procesos respiratorios que cursan con secreción mucosa excesiva o espesa tales como bronquitis aguda y crónica, enfermedad Pulmonar Obstructiva Crónica (EPOC), enfisema, complicaciones pulmonares de la fibrosis quística y otras patologías relacionadas.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar Acetilcisteína Tarbis

No tome Acetilcisteína Tarbis

  • Si es alérgico a acetilcisteína o a alguno de los demás componentes de este medicamento (incluidos en la sección 6).
  • En niños menores de 2 años.

Advertencias y precauciones

Consulte a su médico o farmacéutico antes de empezar a tomar acetilcisteína.

Si es asmático o padece una enfermedad respiratoria grave, debe consultar con el médico antes de tomar este medicamento.

El posible olor azufrado (a huevo podrido) del medicamento es propio del principio activo, pero no indica que el medicamento esté en malas condiciones.

Si al tomar el medicamento observa molestias en el estómago, debe suspender el tratamiento y consultar al médico o farmacéutico. Se recomienda precaución en caso de pacientes con úlcera péptica o antecedentes de úlcera péptica.

Durante los primeros días de tratamiento, podrá observar un aumento de mocos y flemas que irá disminuyendo a lo largo del tratamiento.

Se debe administrar con precaución en el tratamiento de larga duración en pacientes con intolerancia histamínica.

Niños y adolescentes

Está contraindicado en niños menores de 2 años.

Otros medicamentos y Acetilcisteína Tarbis

Informe a su médico o farmacéutico si está tomando, ha tomado recientemente o pudiera tener que tomar cualquier otro medicamento.

La terapia conjunta con nitroglicerina puede producir dolor de cabeza y se debe controlar la aparición de hipotensión, que puede ser grave.

La administración conjunta con el antiepiléptico carbamazepina puede provocar una disminución de la eficacia de carbamazepina.

No tomar conjuntamente con medicamentos antitusivos (para la tos) o con aquellos que disminuyen las secreciones bronquiales (como los antihistamínicos y los anticolinérgicos), ya que se puede provocar un acúmulo de moco fluidificado.

Cuando esté tomando algún medicamento que contenga minerales como el hierro o calcio, o algún medicamento con antibióticos (tipo amfotericina B, ampicilina sódica, cefalosporinas, lactobionato, eritromicina y algunas tetraciclinas), debe separar su toma de la toma de acetilcisteína al menos 2 horas.

No se recomienda la disolución de acetilcisteina con otros medicamentos.

Toma de Acetilcisteína Tarbis con alimentos y bebidas

La toma de alimentos y bebidas no afecta a la eficacia de este medicamento.

Embarazo, lactancia y fertilidad

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

Se debe evitar su toma durante la lactancia.

Conducción y uso de máquinas

No existen evidencias de efectos sobre la capacidad para conducir y utilizar máquinas.

Advertencia sobre excipientes

Este medicamento contiene menos de 1mmol de sodio (23 mg) por sobre; esto es esencialmente “exento de sodio”.

3. Cómo tomar Acetilcisteína Tarbis

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico o farmacéutico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

La dosis recomendada es:

Adultos, adolescentes y niños mayores de 7 años:

200 mg de acetilcisteína (1 sobre de acetilcisteína 200 mg, 3 veces al día), cada 8 horas. No superar la dosis de 3 sobres (600 mg de acetilcisteína) al día.

Complicaciones pulmonares de la fibrosis quística

La dosis recomendada es:

Adultos, adolescentes y niños mayores de 7 años:

200 a 400 mg de acetilcisteína cada 8 horas (1 a 2 sobres de acetilcisteína 200 mg, 3 veces al día).

Acetilcisteína se toma por vía oral.

Los sobres se toman disueltos en un vaso de agua, mezclando con una cucharita. Se recomienda beber abundante cantidad de líquido durante el día.

Está contraindicado en niños menores de 2 años.

Si toma más Acetilcisteína Tarbis del que debe

Si toma más acetilcisteína del que debe, puede notar: náuseas, vómitos, ardor y dolor de estómago, diarrea o cualquier otro efecto adverso descrito en la sección 4. Posibles efectos adversos.

En caso de sobredosis o ingestión accidental, consulte a su médico o farmacéutico o bien llame al Servicio de Información Toxicológica, teléfono 915 620 420, indicando en medicamento y la cantidad tomada.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Si olvidó tomar Acetilcisteína Tarbis

No tome una dosis doble para compensar la dosis olvidada.

Si interrumpe el tratamiento con Acetilcisteína Tarbis

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas lo sufran.

Se pueden producir los siguientes efectos adversos:

Poco frecuentes (pueden afectar hasta 1 de cada 100 personas): hipersensibilidad, dolor de cabeza, zumbido de oídos, taquicardia, vómitos, diarrea, estomatitis, dolor abdominal, náuseas, urticaria, erupción cutánea, angioedema, prurito, aumento de la temperatura corporal, hipotensión.

Raros (pueden afectar hasta 1 de cada 1.000 personas): somnolencia, broncoespasmo, dificultad respiratoria, molestias digestivas.

Muy raros (pueden afectar hasta 1 de cada 10.000 personas): reacciones alérgicas, shock anafiláctico, hemorragia, reacciones cutáneas graves como síndrome de Stevens-Johnson y síndrome de Lyell, en ocasiones identificadas con al menos la toma de otro fármaco de forma simultánea.

Frecuencia no conocida (no puede estimarse a partir de los datos disponibles): hinchazón de la cara.

En caso de producirse cualquier alteración en la piel o membranas mucosas, se debe interrumpir inmediatamente la administración de acetilcisteína y solicitar asistencia médica.

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https://www.notificaRAM.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Acetilcisteína Tarbis

Mantener este medicamento fuera de la vista y del alcance de los niños.

No requiere condiciones especiales de conservación.

No utilice este medicamento después de la fecha de caducidad que aparece en el envase después de CAD. La fecha de caducidad es el último día del mes que se indica.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los

medicamentos que no necesite en el Punto SIGRE de la farmacia. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Acetilcisteína Tarbis

El principio activo es acetilcisteína. Cada sobre contiene 200 mg de acetilcisteína.

Los demás componentes (excipientes) son: manitol, sílice coloidal anhidra, sacarina sódica, aroma de naranja y colorante β- caroteno.

Aspecto del producto y contenido del envase

Acetilcisteína Tarbis 200 mg se presenta en forma de sobres de papel y aluminio con recubrimiento interno de polietileno. Cada envase contiene 30 sobres de granulado de color blanco, ligeramente anaranjado con olor característico.

Titular de la autorización de comercialización y responsable de fabricación

Titular de la autorización de comercialización

Tarbis Farma, S. L.

Gran Vía Carlos III 94

08028 Barcelona

España

Responsable de la fabricación

Farmasierra Manufacturing S. L.

Carretera de I

28709 – San Sebastián de los R adrid.E

Fecha de la última revisión de este prospecto:Julio 2007

La información detallada de este medicamento está disponible en la página web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

( http://www.aemps.gob.es).

Online doctors for ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES

Discuss questions about ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (1084)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€80
5.0 (99)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (147)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (55)
Doctor

Jorge Correa Bellido

General medicine 7 years exp.

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Camera Book a video appointment
€55
5.0 (56)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
0.0 (0)
Doctor

Chikeluo Okeke

General medicine 4 years exp.

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES?
ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES?
The active ingredient in ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES is acetylcysteine. This information helps identify medicines with the same composition but different brand names.
Who manufactures ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES?
ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES is manufactured by Tarbis Farma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ACETYLCYSTEINE TARBIS 200 mg ORAL SOLUTION GRANULES?
Other medicines with the same active substance (acetylcysteine) include ACETYLCYSTEINE ABEX 600 mg EFFERVSCENT TABLETS, ACETYLCYSTEINE ALTER 600 mg EFFERVSCENT TABLETS, ACETYLCYSTEINE AUROVITAS 200 mg EFFERVSCENT TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media